PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,059 | -43.9% | 19,012 | +1.9% | 0.00% | -33.3% |
| Q2 2023 | $758,902 | -16.4% | 18,660 | -0.5% | 0.01% | -25.0% |
| Q1 2023 | $908,008 | +30.9% | 18,745 | +3.2% | 0.01% | +14.3% |
| Q4 2022 | $693,473 | -20.8% | 18,168 | +4.1% | 0.01% | -22.2% |
| Q3 2022 | $876,000 | +25.7% | 17,447 | +0.2% | 0.01% | +28.6% |
| Q2 2022 | $697,000 | +8.6% | 17,405 | +1.2% | 0.01% | +40.0% |
| Q1 2022 | $642,000 | -5.7% | 17,200 | +0.6% | 0.01% | 0.0% |
| Q4 2021 | $681,000 | +5.9% | 17,103 | -1.0% | 0.01% | 0.0% |
| Q3 2021 | $643,000 | -11.6% | 17,272 | +0.4% | 0.01% | -16.7% |
| Q2 2021 | $727,000 | -14.1% | 17,204 | -3.8% | 0.01% | -14.3% |
| Q1 2021 | $846,000 | -21.5% | 17,877 | +1.2% | 0.01% | -30.0% |
| Q4 2020 | $1,078,000 | +35.1% | 17,671 | +3.5% | 0.01% | +25.0% |
| Q3 2020 | $798,000 | +25.7% | 17,074 | +36.4% | 0.01% | -11.1% |
| Q2 2020 | $635,000 | +9.3% | 12,520 | -3.9% | 0.01% | -10.0% |
| Q1 2020 | $581,000 | – | 13,022 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |